These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3370278)

  • 1. Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders.
    Carson SW; Halbreich U; Yeh CM; Goldstein S
    Biol Psychiatry; 1988 May; 24(1):56-62. PubMed ID: 3370278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients.
    Kopp MS; Arató M; Magyar I; Buza K
    Int J Psychophysiol; 1989 Mar; 7(1):77-83. PubMed ID: 2925467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.
    Stein MB; Uhde TW
    Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
    Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
    J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression tests in patients with panic disorder.
    Lieberman JA; Brenner R; Lesser M; Coccaro E; Borenstein M; Kane JM
    Am J Psychiatry; 1983 Jul; 140(7):917-9. PubMed ID: 6859315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test in patients with panic attacks.
    Bridges M; Yeragani VK; Rainey JM; Pohl R
    Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders.
    Grunhaus L; Flegel P; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Mar; 22(3):332-8. PubMed ID: 3814682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of HPA-axis disturbance in panic disorder: a three-year follow-up.
    Coryell W; Noyes R; Reich J
    Biol Psychiatry; 1991 Jan; 29(2):96-102. PubMed ID: 1995088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients.
    Westberg P; Modigh K; Lisjö P; Eriksson E
    Biol Psychiatry; 1991 Aug; 30(3):247-56. PubMed ID: 1912116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in panic disorder: comparison with normal controls.
    Roy-Byrne PP; Bierer LM; Uhde TW
    Biol Psychiatry; 1985 Nov; 20(11):1237-40. PubMed ID: 4052520
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.